Lubricant composition

Information

  • Patent Grant
  • 5073278
  • Patent Number
    5,073,278
  • Date Filed
    Thursday, July 13, 1989
    35 years ago
  • Date Issued
    Tuesday, December 17, 1991
    32 years ago
Abstract
A lubricant based on a mineral or synthetic oil is stabilized against oxidative degradation by the addition of a mixture comprising at least one specified aromatic amine of the formula I ##STR1## and at least one sterically hindered amine. The lubricant may contain other antioxidants or other additives. It is preferably used as motor oil.
Description

The present invention relates to lubricant compositions which are stabilized against oxidative degradation. The stabilization is carried out by the addition of at least two specific additives.
SUMMARY OF THE INVENTION
It is known and customary to add additives to lubricants based on mineral or synthetic oils in order to improve their performance characteristics. Additives against oxidative degradation of the lubricants, the so-called antioxidants, are of particular importance. Oxidative degradation of lubricants plays a significant role especially in motor oils because of the high temperatures prevailing in the combustion chambers of the engines and the presence, in addition to oxygen, of oxides of nitrogen (NO.sub.x) which act as oxidation catalysts.
Aromatic amines, for example alkylated diphenylamines or alkylated phenothiazines, are used inter alia as antioxidants for lubricants. EP-A-149,422 or GB-A-1,090,688, for example, disclose such amines. The use of such aromatic amines in combination with other antioxidants, for example with triarylphosphites, thiodipropionates or phenolic antioxidants, is also known, for example from EP-A-49,133.
We have found that a combination of aromatic amines with sterically hindered amines is a highly suitable antioxidant for lubricants.
The invention provides a lubricant composition which comprises
(A) a mineral or a synthetic base oil or a mixture of such oils,
(B) at least one aromatic amine of the formula I or II, ##STR2## in which R.sup.1 is C.sub.1 -C.sub.18 alkyl, C.sub.7 -C.sub.9 phenylalkyl, C.sub.5 -C.sub.12 cycloalkyl, phenyl, C.sub.7 -C.sub.18 alkylphenyl, C.sub.7 -C.sub.18 alkoxyphenyl or naphthyl, R.sup.2 is phenyl, C.sub.7 -C.sub.18 -alkylphenyl, C.sub.7 -C.sub.18 alkoxyphenyl or naphthyl, R.sup.3 is hydrogen, C.sub.1 -C.sub.12 alkyl, benzyl, allyl, methallyl, phenyl or a group --CH.sub.2 SR.sup.4, R.sup.4 is C.sub.4 -C.sub.18 alkyl, --CH.sub.2 COO(C.sub.4 -C.sub.18 alkyl) or --CH.sub.2 CH.sub.2 COO(C.sub.4 -C.sub.18 alkyl), and R.sup.5 and R.sup.6 independently of one another are H, C.sub.1 -C.sub.18 alkyl or C.sub.7 -C.sub.9 phenylalkyl, and
(C) at least one sterically hindered amine.
DETAILED DESCRIPTION OF THE INVENTION
As C.sub.1 -C.sub.12 alkyl, R.sup.3 may be linear or branched alkyl and may be, for example, methyl, ethyl, propyl, butyl, pentyl, hexyl, octyl, nonyl, decyl or dodecyl. As C.sub.1 -C.sub.18 alkyl, R.sup.1, R.sup.5 and R.sup.6 may in addition also be, for example, tetradecyl, pentadecyl, hexadecyl or octadecyl. As C.sub.4 -C.sub.18 alkyl, R.sup.4 may also be, for example, n-butyl, tert-butyl, n-hexyl, tert-octyl, n-dodecyl or octadecyl.
As C.sub.7 -C.sub.9 phenylalkyl, R.sup.1, R.sup.5 and R.sup.6 may be, for example, benzyl, 2-phenylethyl, .alpha.-methylbenzyl, 2-phenylpropyl or .alpha., .alpha.-dimethylbenzyl.
As C.sub.7 -C.sub.18 alkylphenyl, R.sup.1 and R.sup.2 may have linear or branched alkyl groups. Examples are tolyl, ethylphenyl, isopropylphenyl, tert-butylphenyl, sec-pentylphenyl, n-hexylphenyl, tert-octylphenyl, iso-nonylphenyl or n-dodecylphenyl. R.sup.1 and R.sup.2 may also be mixtures of alkylphenyl groups, such as those produced in industrial alkylations of diphenylamine with olefins. The alkyl group is preferably in the para position of the aromatic amine.
As the component (B), a compound of the formula I or II is preferably used in which R.sup.1 is C.sub.1 -C.sub.4 alkyl, C.sub.7 -C.sub.9 phenylalkyl, cyclohexyl, phenyl, C.sub.10 -C.sub.18 alkylphenyl or naphthyl, R.sup.2 is C.sub.10 -C.sub.18 alkylphenyl or phenyl, R.sup.3 is hydrogen, C.sub.1 -C.sub.8 alkyl, benzyl, allyl or a group --CH.sub.2 SR.sup.4, R.sup.4 is C.sub.8 -C.sub.18 alkyl or --CH.sub.2 COO(C.sub.8 -C.sub.18 alkyl), and R.sup.5 and R.sup.6 independently of one another are H, C.sub.1 -C.sub.12 alkyl or C.sub.7 -C.sub.9 phenylalkyl.
Of the compounds of the formula I those are particularly preferred in which R.sup.1 and R.sup.2 independently of one another are phenyl or C.sub.10 -C.sub.18 alkyl-phenyl and R.sup.3 is hydrogen.
Of the compounds of the formula II those are particularly preferred in which R.sup.3 is hydrogen and R.sup.5 and R.sup.6 independently of one another are H or C.sub.4 -C.sub.12 alkyl.
Examples of compounds of the formula I are:
diphenylamine,
N-allyldiphenylamine
4-isopropoxydiphenylamine
N-phenyl-1-naphthylamine
N-phenyl-2-naphthylamine
di-4-methoxyphenylamine
d-[4-(1,3-dimethylbutyl)phenyl]amine
di-[4-(1,1,3,3-tetramethylbutyl)phenyl]amine
tert-octylated N-phenyl-1-naphthylamine
industrial mixtures obtained by reacting diphenylamine with diisobutylene (mono-, di- and trialkylated tert-butyl- and tert-octyldiphenylamine)
phenothiazine
N-allylpenothiazine
3,7-di-tert-octylphenothiazine
industrial mixtures obtained by reacting phenothiazine with diisobutylene
Particularly preferred component (B) is 4,4'-di-tert-octyldiphenylamine or 3,7-di-tert-octylphenothiazine or an industrial mixture obtained by reacting diphenylamine with diisobutylene, particularly a mixture which contains the following components:
a) not more than 5% by weight of diphenylamine,
b) 8-15% by weight of 4-tert-butyldiphenylamine,
c) 24-32% by weight of 4-tert-octyldiphenylamine, 4,4'-di-tert-butyldiphenylamine and 2,4,4'-tri-tert-butyldiphenylamine,
d) 23-34% by weight of 4-tert-butyl-4'-tert-octyldiphenylamine, 2,2'- and 3,3'-di-tert-octyldiphenylamine and 2,4-di-tert-butyl-4'-tert-octyldiphenylamine,
e) 21-34% by weight of 4,4'-di-tert-octyldiphenylamine and 2,4-di-tert-octyl-4'-tert-butyldiphenylamine.
The component (C) may be any cyclic or acyclic sterically hindered amine. The preferred component (C) is a compound which contains at least one group of the formula III ##STR3## in which R is hydrogen or methyl. R as hydrogen is preferred. The compounds in question are derivatives of polyalkylpiperidines, particularly of 2,2,6,6-tetramethylpiperidine. These polyalkylpiperidines preferably carry one or two polar substituents or a polar spiro ring system in the 4-position.
The following classes of polyalkylpiperidines are particularly important:
a) compounds of the formula IV ##STR4## in which n is an integer of 1 to 4, preferably 1 or 2, R is hydrogen or methyl, R.sup.11 is hydrogen, oxyl, hydroxyl, C.sub.1 -C.sub.12 alkyl, C.sub.3 -C.sub.8 alkenyl, C.sub.3 -C.sub.8 alkynyl, C.sub.7 -C.sub.12 aralkyl, C.sub.1 -C.sub.18 alkoxy, C.sub.5 -C.sub.8 cycloalkoxy, C.sub.7 -C.sub.9 phenylalkoxy, C.sub.1 -C.sub.8 alkanoyl, C.sub.3 -C.sub.5 alkenoyl, C.sub.1 -C.sub.18 alkanoyloxy, benzyloxy, glycidyl or a group --CH.sub.2 CH(OH)--Z, in which Z is hydrogen, methyl or phenyl, R.sup.11 being preferably H, C.sub.1 -C.sub.4 alkyl, allyl, benzyl, acetyl or acryloyl and R.sup.12 being, when n is 1, hydrogen, C.sub.1 -C.sub.18 alkyl which is uninterrupted or interrupted by one or more oxygen atoms, cyanoethyl, benzyl, glycidyl, a monobasic radical of an aliphatic, cycloaliphatic, araliphatic, unsaturated or aromatic carboxylic acid, carbamic acid or a phosphorus-containing acid or a monovalent silyl radical, preferably a radical of an aliphatic carboxylic acid having 2 to 18 carbon atoms, of a cycloaliphatic carboxylic acid having 7 to 15 carbon atoms, of an .alpha.,.beta.-unsaturated carboxylic acid having 3 to 5 carbon atoms or of an aromatic carboxylic acid having 7 to 15 carbon atoms, R.sup.12 being, when n is 2, C.sub.1 -C.sub.12 alkylene, C.sub.4 -C.sub.12 alkenylene, xylylene, a dibasic radical of an aliphatic, cycloaliphatic, araliphatic or aromatic dicarboxylic acid, dicarbamic acid or a phosphorus-containing acid or a divalent silyl radical, preferably a radical of an aliphatic dicarboxylic acid having 2 to 36 carbon atoms, a cycloaliphatic or aromatic dicarboxylic acid having 8 to 14 carbon atoms or an aliphatic, cycloaliphatic or aromatic dicarbamic acid having 8 to 14 carbon atoms, R.sup.12 being, when n is 3, a tribasic radical of an aliphatic, cycloaliphatic or aromatic tricarboxylic acid, an aromatic tricarbamic acid or a phosphorus-containing acid or a trivalent silyl radical, and R.sup.12 being, when n is 4, a tetrabasic radical of an aliphatic, cycloaliphatic or aromatic tetracarboxylic acid.
Any C.sub.1 -C.sub.12 alkyl substituents present are, for example, methyl, ethyl, n-propyl, n-butyl, sec-butyl, tert-butyl, n-hexyl, n-octyl, 2-ethylhexyl, n-nonyl, n-decyl, n-undecyl or n-dodecyl.
As C.sub.1 -C.sub.18 alkyl, R.sup.11 or R.sup.12 may be, for example, the above groups and additionally, for example, n-tridecyl, n-tetradecyl, n-hexadecyl or n-octadecyl.
As C.sub.3 -C.sub.8 alkenyl, R.sup.11 is, for example, 1-propenyl, allyl, methallyl, 2-butenyl, 2-pentenyl, 2-hexenyl, 2-octenyl and 4-tert-butyl-2-butenyl.
As C.sub.3 -C.sub.8 alkynyl, R.sup.11 is preferably propargyl.
As C.sub.7 -C.sub.12 aralkyl, R.sup.11 is particularly phenethyl and above all benzyl.
As C.sub.1 -C.sub.8 alkanoyl, R.sup.11 is , for example, formyl, propionyl, butyryl, octanoyl, but preferably acetyl; and as C.sub.3 -C.sub.5 alkenoyl, R.sup.11 is particularly acryloyl.
As a monobasic radical of a carboxylic acid, R.sup.12 is a radical, for example, of acetic acid, caproic acid, stearic acid, acrylic acid, methacrylic acid, benzoic acid or .beta.-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionic acid.
As a dibasic radical of a dicarboxylic acid, R.sup.12 is a radical, for example, of malonic acid, succinic acid, glutaric acid, adipic acid, suberic acid, sebacic acid, maleic acid, itaconic acid, phthalic acid, dibutylmalonic acid, dibenzylmalonic acid, butyl(3,5-di-tert-butyl-4-hydroxybenzyl)malonic acid or bicycloheptenedicarboxylic acid.
As a tribasic radical of a tricarboxylic acid, R.sup.12 is a radical, for example, of trimellitic acid, citric acid or nitrilotriacetic acid.
As a tetrabasic radical of a tetracarboxylic acid, R.sup.12 is the tetrabasic radical, for example, of butane-1,2,3,4-tetracarboxylic acid or of pyromellitic acid.
As a dibasic radical of a dicarbamic acid, R.sup.12 is a radical, for example, of hexamethylenedicarbamic acid or 2,4-toluylenedicarbamic acid.
Preferred compounds of the formula IV are those in which R is hydrogen, R.sup.11 is hydrogen or methyl, n is 2 and R.sup.12 is the diacyl radical of an aliphatic dicarboxylic acid having 4 to 12 carbon atoms.
Examples of polyalkylpiperidine compounds of this class are the following compounds:
1) 4-hydroxy-2,2,6,6-tetramethylpiperidine
2) 1-allyl-4-hydroxy-2,2,6,6-tetramethylpiperidine
3) 1-benzyl-4-hydroxy-2,2,6,6-tetramethylpiperidine
4) 1-(4-tert-butyl-2-butenyl)-4-hydroxy-2,2,6,6-tetramethylpiperidine
5) 4-stearoyloxy-2,2,6,6-tetramethylpiperidine
6) 1-ethyl-4-salicyloyloxy-2,2,6,6-tetramethylpiperidine
7) 4-methacryloyloxy-1,2,2,6,6-pentamethylpiperidine
8) 1,2,2,6,6-pentamethylpiperidin-4-yl-(3,5-di-tert-butyl-4-hydroxyphenyl) propionate
9) di-(1-benzyl-2,2,6,6-tetramethylpiperidin-4-yl) maleate
10) di-(2,2,6,6-tetramethylpiperidin-4-yl) succinate
11) di-(2,2,6,6-tetramethylpiperidin-4-yl) glutarate
12) di-(2,2,6,6-tetramethylpiperidin-4-yl) adipate
13) di-(2,2,6,6-tetramethylpiperidin-4-yl) sebacate
14) di-(1,2,2,6,6-pentamethylpiperdin-4-yl) sebacate
15) di-(1,2,3,6-tetramethyl-2,6-diethylpiperidin-4-yl) sebacate
16) di-(1-allyl-2,2,6,6-tetramethylpiperidin-4-yl) phthalate
17) 1-hydroxy-4-cyanoethyloxy-2,2,6,6-tetramethylpiperidine
18) 1-acetyl-2,2,6,6-tetramethylpiperidin-4-yl acetate
19) tri-(2,2,6,6-tetramethylpiperidin-4-yl) trimellitate
20) 1-acryloyl-4-benzyloxy-2,2,6,6-tetramethylpiperidine
21) di-(2,2,6,6-tetramethylpiperidin-4-yl) diethylmalonate
22) di-(1,2,2,6,6-pentamethylpiperidin-4-yl) dibutylmalonate
23) di-(1,2,2,6,6-pentamethylpiperidin-4-yl) butyl-(3,5-di-tert-butyl-4-hydroxybenzyl) malonate
24) di(1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl) sebacate
25) di(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl) sebacate
26) hexane-1',6'-bis(4-carbamoyloxy-1-n-butyl-2,2,6,6-tetramethylpiperidine)
27) toluene-2',4'-bis(4-carbamoyloxy-1-n-propyl-2,2,6,6-tetramethylpiperidine)
28) dimethyl-bis(2,2,6,6-tetramethylpiperidin-4-oxy)silane
29) phenyl-tris(2,2,6,6-tetramethylpiperidin-4-oxy)silane
30) tris(1-propyl-2,2,6,6-tetramethylpiperidin-4-yl) phosphite
31) tris(1-propyl-2,2,6,6-tetramethylpiperidin-4-yl) phosphate
32) phenyl[bis-(1,2,2,6,6-pentamethylpiperidin-4-yl)] phosphonate
33) 4-hydroxy-1,2,2,6,6-pentamethylpiperidine
34) 4-hydroxy-N-hydroxyethyl-2,2,6,6-tetramethylpiperidine
35) 4-hydroxy-N-(2-hydroxypropyl)-2,2,6,6-tetramethylpiperidine
36) 1-glycidyl-4-hydroxy-2,2,6,6-tetramethylpiperidine
b) compounds of the formula (V) ##STR5## in which n is the integer 1 or 2, R and R.sup.11 have the meaning defined in a), R.sup.13 is hydrogen, C.sub.1 -C.sub.12 alkyl, C.sub.2 -C.sub.5 hydroxyalkyl, C.sub.5 -C.sub.7 cycloalkyl, C.sub.7 -C.sub.8 aralkyl, C.sub.2 -C.sub.18 alkanoyl, C.sub.3 -C.sub.5 alkenoyl, benzoyl or a group of the formula ##STR6## and when n is 1, R.sup.14 is hydrogen, C.sub.1 -C.sub.18 alkyl, C.sub.3 -C.sub.8 alkenyl, C.sub.5 -C.sub.7 cycloalkyl, C.sub.1 -C.sub.4 alkyl substituted by a hydroxyl, cyano, alkoxycarbonyl or carbamide group, glycidyl, a group of the formula --CH.sub.2 --CH(OH)--Z or the formula --CONH--Z, in which Z is hydrogen, methyl or phenyl; when n is 2, R.sup.14 is C.sub.2 -C.sub.12 alkylene, C.sub.6 -C.sub.12 arylene, xylylene, a --CH.sub.2 --CH(OH)--CH.sub.2 -- group or a --CH.sub.2 --CH(OH)--CH.sub.2 --O--D--O-- group, in which D is C.sub.2 -C.sub.10 alkylene, C.sub.6 -C.sub.15 arylene, C.sub.6 -C.sub.12 cycloalkylene, or, if R.sup.13 is not alkanoyl, alkenoyl or benzoyl, R.sup.14 can also be a dibasic radical of an aliphatic, cycloaliphatic or aromatic dicarboxylic acid or dicarbamic acid or also the group --CO--, or when n is 1, R.sup.13 and R.sup.14 together can be the dibasic radical of an aliphatic, cycloaliphatic or aromatic 1,2- or 1,3-di-carboxylic acid.
Any C.sub.1 -C.sub.12 alkyl or C.sub.1 -C.sub.18 alkyl substituents present have the meaning already defined in a).
Any C.sub.5 -C.sub.7 cycloalkyl substituents present are particularly cyclohexyl.
As C.sub.7 -C.sub.8 aralkyl, R.sup.13 is particularly phenylethyl or above all benzyl. As C.sub.2 -C.sub.5 hydroxyalkyl, R.sup.13 is particularly 2-hydroxyethyl or 2-hydroxypropyl.
As C.sub.2 -C.sub.18 alkanoyl, R.sup.13 is for example propionyl, butyryl, octanoyl, dodecanoyl, hexadecanoyl, octadecanoyl, but preferably acetyl, and as C.sub.3 -C.sub.5 alkenoyl, R.sup.13 is particularly acryloyl.
As C.sub.2 -C.sub.8 alkenyl, R.sup.14 is for example allyl, methallyl, 2-butenyl, 2-pentenyl, 2-hexenyl or 2-octenyl.
As C.sub.1 -C.sub.4 alkyl substituted by a hydroxyl, cyano, alkoxycarbonyl or carbamide group, R.sup.14 can be, for example, 2-hydroxyethyl, 2-hydroxypropyl, 2-cyanoethyl, methoxycarbonylmethyl, 2-ethoxycarbonylethyl, 2-aminocarbonylpropyl or 2-(dimethylaminocarbonyl)ethyl.
Any C.sub.2 -C.sub.12 alkylene substituents present are, for example, ethylene, propylene, 2,2-dimethylpropylene, tetramethylene, hexamethylene, octamethylene, decamethylene or dodecamethylene.
Any C.sub.6 -C.sub.15 arylene substituents present are, for example, o-, m- or p-phenylene, 1,4-naphthylene or 4,4'-diphenylene.
As C.sub.6 -C.sub.12 cycloalkylene, D is especially cyclohexylene.
Preferred compounds of the formula V are those in which n is 1 or 2, R is hydrogen, R.sup.11 is hydrogen or methyl, R.sup.13 is hydrogen, C.sub.1 -C.sub.12 alkyl or a group of the formula ##STR7## and when n=1, R.sup.14 is hydrogen or C.sub.1 -C.sub.12 alkyl, and when n=2, R.sup.14 is C.sub.2 -C.sub.8 alkylene.
Examples of polyalkylpiperidine compounds of this class are the following compounds:
37) N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylene-1,6-diamine
38) N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylene-1,6-diacetamide
39) bis(2,2,6,6-tetramethylpiperidin-4-yl)amine
40) 4-benzoylamino-2,2,6,6-tetramethylpiperidine
41) N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)-N,N'-dibutyladipamide
42) N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)-N,N'-dicyclohexyl-2-hydroxypropylene-1,3-diamine
43) N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)-p-xylylenediamine
44) N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)succindiamide
45) di(2,2,6,6-tetramethylpiperidin-4-yl) N-(2,2,6,6-tetramethylpiperidin-4-yl)-aminodipropionate
46) The compound of the formula ##STR8## 47) 4-(bis-2-hydroxyethylamino)-1,2,2,6,6-pentamethylpiperidine 48) 4-(3-methyl-4-hydroxy-5-tert-butylbenzoamido)-2,2,6,6-tetramethylpiperidine
49) 4-methacrylamido-1,2,2,6,6-pentamethylpiperidine
c) compounds of the formula (VI) ##STR9## in which n is the integer 1 or 2, R and R.sup.11 have the meaning defined in a), and when n is 1, R.sup.15 is C.sub.2 -C.sub.8 alkylene or C.sub.2 -C.sub.8 hydroxyalkylene or C.sub.4 -C.sub.22 acyloxyalkylene, and when n is 2, R.sup.15 is the group (--CH.sub.2).sub.2 C(CH.sub.2 --).sub.2.
As C.sub.2 -C.sub.8 alkylene or C.sub.2 -C.sub.8 hydroxyalkylene, R.sup.15 is for example ethylene, 1-methylethylene, propylene, 2-ethylpropylene or 2-ethyl-2-hydroxymethylpropylene.
As C.sub.4 -C.sub.22 acyloxyalkylene, R.sup.15 is for example 2-ethyl-2-acetoxymethylpropylene.
Examples of polyalkylpiperidine compounds of this class are the following compounds:
50) 9-aza-8,8,10,10-tetramethyl-1,5-dioxaspiro[5.5]undecane
51) 9-aza-8,8,10,10-tetramethyl-3-ethyl-1,5-dioxaspiro[5.5]undecane
52) 8-aza-2,7,7,8,9,9-hexamethyl-1,4-dioxaspiro[4.5]decane
53) 9-aza-3-hydroxymethyl-3-ethyl-8,8,9,10,10-pentamethyl-1,5-dioxaspiro[5.5]undecane
54) 9-aza-3-ethyl-3-acetoxymethyl-9-acetyl-8,8,10,10-tetramethyl-1,5-dioxaspiro[5.5]undecane
55) 2,2,6,6-tetramethylpiperidine-4-spiro-2'-(1',3'-dioxan)-5'-spiro-5"-(1",3"-dioxan)-2"-spiro-4"'-(2"',2'",6"',6"'-tetramethylpiperidine).
d) compounds of the formulae VIIA, VIIB and VIIC ##STR10## in which n is the integer 1 or 2, R and R.sup.11 have the meaning defined in a), R.sup.16 is hydrogen, C.sub.1 -C.sub.12 alkyl, allyl, benzyl, glycidyl or C.sub.2 -C.sub.6 alkoxyalkyl, and when n is 1, R.sup.17 is hydrogen, C.sub.1 -C.sub.12 alkyl, C.sub.3 -C.sub.5 alkenyl, C.sub.7 -C.sub.9 aralkyl, C.sub.5 -C.sub.7 cycloalkyl, C.sub.2 -C.sub.4 hydroxyalkyl, C.sub.2 -C.sub.6 alkoxyalkyl, C.sub.6 -C.sub.10 aryl, glycidyl or a group of the formula --(CH.sub.2)p--COO--Q or the formula --(CH.sub.2)p--O--CO--Q, in which p is 1 or 2 and Q is C.sub.1 -C.sub.4 alkyl or phenyl, and when n is 2, R.sup.17 is C.sub.2 -C.sub.12 alkylene, C.sub.4 -C.sub.12 alkenylene, C.sub.6 -C.sub.12 arylene, a group --CH.sub.2 --CH(OH)--CH.sub.2 --O--D--O--CH.sub.2 --CH(OH)--CH.sub.2 --, in which D is C.sub. 2 -C.sub.10 alkylene, C.sub.6 -C.sub.15 arylene, C.sub.6 -C.sub.12 cycloalkylene or a group --CH.sub.2 CH(OZ')CH.sub.2 --(OCH.sub.2 CH(OZ')CH.sub.2).sub.2 --, in which Z' is hydrogen, C.sub.1 -C.sub.18 alkyl, allyl, benzyl, C.sub.2 -C.sub.12 alkanoyl or benzoyl, T.sub.1 and T.sub.2 independently of one another are hydrogen, C.sub.1 -C.sub.18 alkyl or C.sub.6 -C.sub.10 aryl or C.sub.7 -C.sub.9 aralkyl which are unsubstituted or substituted by halogen or C.sub.1 -C.sub.4 alkyl, or T.sub.1 and T.sub.2 together form with the carbon atom connecting them a C.sub.5 -C.sub.12 cycloalkane ring.
Any C.sub.1 -C.sub.12 alkyl substituents present are, for example, methyl, ethyl, n-propyl, n-butyl, sec-butyl, tert-butyl, n-hexyl, n-octyl, 2-ethylhexyl, n-nonyl, n-decyl, n-undecyl or n-dodecyl.
Any C.sub.1 -C.sub.18 alkyl substituents present can be, for example, the groups defined above and additionally also, for example, n-tridecyl, n-tetradecyl, n-hexadecyl or n-octadecyl.
Any C.sub.2 -C.sub.6 alkoxyalkyl substituents present are, for example, methoxymethyl, ethoxymethyl, propoxymethyl, tert-butoxymethyl, ethoxyethyl, ethoxypropyl, n-butoxyethyl, tert-butoxyethyl, isopropoxyethyl or propoxypropyl.
As C.sub.3 -C.sub.5 alkenyl, R.sup.17 is, for example, 1-propenyl, allyl, methallyl, 2-butenyl or 2-pentenyl.
As C.sub.7 -C.sub.9 aralkyl, R.sup.17, T.sub.1 and T.sub.2 are particularly phenethyl or above all benzyl. Any cycloalkane ring formed by T.sub.1 and T.sub.2 together with the carbon atom can be, for example, a cyclopentane, cyclohexane, cyclooctane or cyclododecane ring.
As C.sub.2 -C.sub.4 hydroxyalkyl, R.sup.17 is, for example, 2-hydroxyethyl, 2-hydroxypropyl, 2-hydroxybutyl or 4-hydroxybutyl.
As C.sub.6 -C.sub.10 aryl, R.sup.17, T.sub.1 and T.sub.2 are especially phenyl, .alpha.- or .beta.-naphthyl which are unsubstituted or substituted by halogen or C.sub.1 -C.sub.4 alkyl.
As C.sub.2 -C.sub.12 alkylene, R.sup.17 is, for example, ethylene, propylene, 2,2-dimethylpropylene, tetramethylene, hexamethylene, octamethylene, decamethylene or dodecamethylene.
As C.sub.4 -C.sub.12 alkenylene, R.sup.17 is particularly 2-butenylene, 2-pentenylene or 3-hexenylene.
As C.sub.6 -C.sub.12 arylene, R.sup.17 is, for example, o-, m- or p-phenylene, 1,4-naphthylene or 4,4'-diphenylene.
As C.sub.2 -C.sub.12 alkanoyl, Z' is, for example, propionyl, butyryl, octanoyl, dodecanoyl, but preferably acetyl.
As C.sub.2 -C.sub.10 alkylene, C.sub.6 -C.sub.15 arylene or C.sub.6 -C.sub.12 cycloalkylene, D has the meaning defined in b).
Examples of polyalkylpiperidine compounds of this class are the following compounds:
56) 3-benzyl-1,3,8-triaza-7,7,9,9-tetramethylspiro[4.5]decane-2,4-dione
57) 3-n-octyl-1,3,8-triaza-7,7,9,9-tetramethylspiro[4.5]decane-2,4-dione
58) 3-allyl-1,3,8-triaza-1,7,7,9,9-pentamethylspiro[4.5]decane-2,4-dione
59) 3-glycidyl- 1,3,8-triaza-7,7,8,9,9-pentamethylspiro[4.5]decane-2,4-dione
60) 1,3,7,7,8,9,9-heptamethyl-1,3,8-triazaspiro[4.5]decane-2,4-dione
61) 2-iso-propyl-7,7,9,9-tetramethyl-1-oxa-3,8-diaza-4-oxo-spiro[4.5]-decane
62) 2,2-dibutyl-7,7,9,9-tetramethyl-1-oxa-3,8-diaza-4-oxospiro[4.5]decane
63) 2,2,4,4-tetramethyl-7-oxa-3,20-diaza-21-oxodispiro 5.1.11.2]-heneicosane
64) 2-butyl-7,7,9,9-tetramethyl-1-oxa-4,8-diaza-3-oxospiro[4.5]decane
65) 8-acetyl-3-dodecyl-1,3,8-triaza-7,7,9,9-tetramethylspiro[4.5]decane-2,4-dione
or the compounds of the following formulae: ##STR11##
e) compounds of the formula VIII ##STR12## in which n is the integer 1 or 2 and R.sup.18 is a group of the formula ##STR13## in which R and R.sup.11 have the meaning defined in a), E is --O-- or --NR.sup.11 --, A is C.sub.2 -C.sub.6 alkylene or --(CH.sub.2).sub.3 --O--, and x is the integers 0 or 1, R.sup.19 is the same as R.sup.18 or is one of the groups --NR.sup.21 R.sup.22, --OR.sup.23, --NHCH.sub.2 OR.sup.23 or --N(CH.sub.2 OR.sup.23).sub.2, and when n is 1, R.sup.20 is the same as R.sup.18 or R.sup.19, and when n=2, R.sup.20 is a group --E--B--E--, in which B is C.sub.2 -C.sub.6 alkylene which is uninterrupted or interrupted by --N(R.sup.21)--, R.sup.11 is C.sub.1 -C.sub.12 alkyl, cyclohexyl, benzyl or C.sub.1 -C.sub.4 hydroxyalkyl or a group of the formula ##STR14## R.sup.22 is C.sub.1 -C.sub.12 alkyl, cyclohexyl, benzyl, C.sub.1 -C.sub.4 hydroxyalkyl, and R.sup.23 is hydrogen, C.sub.1 -C.sub.12 alkyl or phenyl, or R.sup.21 and R.sup.22 together are C.sub.4 -C.sub.5 -alkylene or C.sub.4 -C.sub.5 oxaalkylene, for example ##STR15## or R.sup.21 and R.sup.22 in each case are also a group of the formula ##STR16##
Any C.sub.1 -C.sub.12 alkyl substituents present are, for example, methyl, ethyl, n-propyl, n-butyl, sec-butyl, tert-butyl, n-hexyl, n-octyl, 2-ethylhexyl, n-nonyl, n-decyl, n-undecyl or n-dodecyl.
Any C.sub.1 -C.sub.4 hydroxyalkyl substituents present are, for example, 2-hydroxyethyl, 2-hydroxypropyl, 3-hydroxypropyl, 2-hydroxybutyl or 4-hydroxybutyl.
C.sub.2 -C.sub.6 alkylene as A is, for example, ethylene, propylene, 2,2-dimethylpropylene, tetramethylene or hexamethylene.
C.sub.4 -C.sub.5 alkylene or C.sub.4 -C.sub.5 oxaalkylene as R.sup.21 and R.sup.22 together are, for example, tetramethylene, pentamethylene or 3-oxapentamethylene.
Examples of polyalkylpiperidine compounds of this class are the compounds of the following formulae: ##STR17##
f) oligomers or polymeric compounds whose recurring structural unit comprises a 2,2,6,6-tetraalkylpiperidine radical of the formula (I), particularly polyesters, polyethers, polyamides, polyamines, polyurethanes, polyureas, polyaminotriazines, poly(meth)acrylates, poly(meth)acrylamide and their copolymers which comprise such radicals.
Examples of 2,2,6,6-polyalkylpiperidine light stabilizers of this class are the compounds of the following formulae where m is an integer of 2 to about 200. ##STR18## in which R and R.sup.11 have the meaning defined in a).
Preferred compounds of the formula IX are those in which R is hydrogen or methyl and R.sup.11 is hydrogen or methyl.
Examples of such compounds are:
95) 2,2,6,6-tetramethyl-4-piperidone (triacetonamine)
96) 1,2,2,6,6-pentamethyl-4-piperidone
97) 2,2,6,6-tetramethyl-4-piperidon-1-oxyl
98) 2,3,6-trimethyl-2,6-diethyl-4-piperidone
The amount of (B) and (C) added to the base oil (A) depends on the type of the base oil and the desired degree of stabilization. Generally the total of (B) and (C) is 0.1 to 2% by weight, preferably 0.5 to 1% by weight, based on (A). The ratio of (B) to (C) can vary within wide limits; (B) is generally the quantitatively dominant component. The ratio (B):(C) is preferably 3-5:1.
The component (A) is a mineral or synthetic base oil, such as is normally used for the production of lubricants. Synthetic oils may be, for example, esters of polycarboxylic acids or of polyols; they may also be aliphatic polyesters or poly-.alpha.-olefins, silicones, phosphoric acid esters or polyalkylene glycols. The lubricant may also be a grease based on an oil and a thickener. Such lubricants are described, for example, in D. Klamann "Schmierstoffe und artverwandte Produkte" ["Lubricants and Related Products"], Verlag Chemie, Weinheim 1982.
The lubricant may additionally contain other additives, for example other antioxidants, metal passivators, rust inhibitors, viscosity index improvers, pour point depressants, dispersants, surfactants or antiwear additives.
EXAMPLES OF PHENOLIC ANTIOXIDANTS
1. Alkylated Monophenolics
2,6-di-tert-butyl-4-methylphenol, 2,6-di-tert-butylphenol, 2-tert-butyl-4,6-dimethylphenol, 2,6-di-tert-butyl-4-ethylphenol, 2,6-di-tert-butyl-4-n-butylphenol, 2,6-di-tert-butyl-4-iso-butylphenol, 2,6-dicyclopentyl-4-methylphenol, 2-(.alpha.-methylcyclohexyl)-4,6-dimethylphenol, 2,6-dioctadecyl-4-methylphenol, 2,4,6-tricyclohexylphenol, 2,6-di-tert-butyl-4-methoxymethylphenol, o-tert-butylphenol.
2. Alkylated Hydroquinones
2,6-di-tert-butyl-4-methoxyphenol, 2,5-di-tert-butylhydroquinone, 2,5-di-tert-amylhydroquinone, 2,6-diphenyl-4-octadecyloxyphenol.
3. Hydroxylated Thiodiphenyl Ethers
2,2'-thio-bis(6-tert-butyl-4-methylphenol), 2,2'-thio-bis(4-octylphenol), 4,4'-thio-bis(6-tert-butyl-3-methylphenol), 4,4'-thio-bis(6-tert-butyl-2-methylphenol).
4. Alkylidene Bisphenols
2,2'-methylene-bis(6-tert-butyl-4-methylphenol), 2,2'-methylene-bis(6-tert-butyl-4-ethylphenol), 2,2'-methylene-bis[4-methyl-6-(?-methylcyclohexyl)phenol], 2,2'-methylene-bis(4-methyl-6-cyclohexylphenol), 2,2'-methylene-bis(6-nonyl-4-methylphenol), 2,2'-methylene-bis(4,6-di-tert-butylphenol), 2,2'-ethylidene-bis(4,6-di-tert-butylphenol), 2,2'-ethylidene-bis(6-tert-butyl-4-isobutylphenol or -5-isobutylphenol), 2,2'-methylene-bis[6-(.alpha.-methylbenzyl)-4-nonylphenol], 2,2'-methylene-bis[6-(.alpha.,.alpha.-dimethylbenzyl)-4-nonylphenol], 4,4'-methylene-bis(2,6-di-tert-butylphenol), 4,4'-methylene-bis(6-tert-butyl-2-methylphenol), 1,1-bis(5-tert-butyl-4-hydroxy-2-methylphenyl)butane, 2,6-di(3-tert-butyl-5-methyl-2-hydroxybenzyl)-4-methylphenol, 1,1,3-tris(5-tert-butyl-4-hydroxy-2-methylphenyl)-3-n-dodecylmercaptobutane, ethylene glycol bis[3,3-bis(3'-tert-butyl-4'-hydroxyphenyl)butyrate], bis(3-tert-butyl-4-hydroxy-5-methylphenyl)dicyclopentadiene, bis[2-(3'-tert-butyl-2'-hydroxy-5'-methylbenzyl)-6-tert-butyl-4-methylphenyl]terephthalate.
5. Benzyl Compounds
1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)-2,4,6-trimethylbenzene, bis(3,5-di-tert-butyl-4-hydroxybenzyl) sulfide, isooctyl 3,5-di-tert-butyl-4-hydroxybenzylmercaptoacetate, bis(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl)dithiol terephthalate, 1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl) isocyanurate, 1,3,5-tris(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl) isocyanurate, dioctadecyl 3,5-di-tert-butyl-4-hydroxybenzylphosphonate, monoethyl 3,5-di-tert-butyl-4-hydroxybenzylphosphonate calcium salt.
6. Acylaminophenols
4-hydroxylauranilide, 4-hydroxystearanilide, 2,4-bis-octylmercapto-6-(3,5-di-tert-butyl-4-hydroxyanilino)-s-triazine, octyl N-(3,5-di-tert-butyl-4-hydroxyphenyl)carbamate.
7. Esters of .beta.-(3,5-di-tert-butyl-4-hydroxyphenyl)propionic acid
with monohydric or polyhydric alcohols, for example with methanol, diethylene glycol, octadecanol, triethylene glycol, 1,6-hexanediol, pentaerythritol, neopentyl glycol, trishydroxyethyl isocyanurate, thiodiethylene glycol, bishydroxyethyloxalic acid diamide.
8. Esters of .beta.-(5-tert-butyl-4-hydroxy-3-methylphenyl)propionic acid
with monohydric or polyhydric alcohols, for example with methanol, diethylene glycol, octadecanol, triethylene glycol, 1,6-hexanediol, pentaerythritol, neopentyl glycol, tris-hydroxyethyl isocyanurate, thiodiethylene glycol, dihydroxyethyloxalic acid diamide.
9. Amides of .beta.-(3,5-di-tert-butyl-4-hydroxyphenyl)propionic acid
for example N,N'-bis(3,5-di-tert-butyl-4-hydroxyphenylpropionyl)hexamethylenediamine, N,N'-bis(3,5-di-tert-butyl-4-hydroxyphenylpropionyl)trimethylenediamine, N,N'-bis(3,5-di-tert-butyl-4-hydroxyphenylpropionyl)hydrazine.
EXAMPLES OF OTHER ANTIOXIDANTS
aliphatic or aromatic phosphites, esters of thiodipropionic acid or of thiodiacetic acid, or salts of dithiocarbamide acid or dithiophosphoric acid.
EXAMPLES OF METAL DEACTIVATORS FOR EXAMPLE FOR COPPER
triazoles, benzotriazoles and their derivatives, tolutriazoles and their derivatives, 2-mercaptobenzothiazole, 2-mercaptobenzotriazole, 2,5-dimercaptobenzotriazole, 2,5-dimercaptobenzothiadiazole, 5,5'-methylenebisbenzotriazole, 4,5,6,7-tetrahydrobenzotriazole, salicylidenepropylenediamine, salicylaminoguanidine and their salts.
EXAMPLES OF RUST INHIBITORS
a) Organic acids and esters, metal salts and anhydrides thereof, for example: N-oleoylsarcosine, sorbitol monooleate, lead naphthenate, alkenylsuccinic anhydride, for example dodecenylsuccinic anhydride, alkenylsuccinic acid hemiesters and hemi-amides, and 4-nonylphenoxyacetic acid.
b) Nitrogenous compounds, for example:
I. primary, secondary or tertiary aliphatic or cycloaliphatic amines and amine salts of organic and inorganic acids, for example oil-soluble alkylammonium carboxylates.
II. heterocyclic compounds, for example: substituted imidazolines and oxazolines.
c) Phosphorus compounds, for example: amine salts of partial esters of phosphoric acid or partial esters of phosphonic acid, zinc dialkyldithiophosphates.
d) Sulfur compounds, for example: barium dinonylnaphthalenesulfonates, calcium petroleum sulfonates.
EXAMPLES OF VISCOSITY INDEX IMPROVERS
polyacrylates, polymethacrylates, vinylpyrrolidone/methacrylate copolymers, polyvinylpyrrolidones, polybutenes, olefin copolymers, styrene/acrylate copolymers, polyethers.
EXAMPLES OF POUR POINT DEPRESSANTS
polymethacrylate, alkylated naphthalene derivatives.
EXAMPLES OF DISPERSANTS/SURFACTANTS
polybutenylsuccinamides or -imides, polybutenylphosphonic acid derivatives, basic magnesium, calcium and barium sulfonates and phenolates.
EXAMPLES OF ANTIWEAR ADDITIVES
compounds containing sulfur and/or phosphorus and/or halogen, such as sulfurized vegetable oils, zinc dialkyldithiophosphates, tritolylphosphate, chlorinated paraffins, alkyl sulfides, aryl disulfides and aryl trisulfides, triphenylphosphorothionates, diethanolaminomethyltolyltriazole, di(2-ethylhexyl)aminomethyltolyltriazole.
The addition of phenolic antioxidants and/or of aliphatic and aromatic phosphites or phosphonites which are capable of increasing the stabilizing effect of the components (B) and (C), is particularly important.
Examples of suitable phosphites and phosphonites are: triphenyl phosphite, decyldiphenyl phosphite, phenyldidecyl phosphite, tris(nonylphenyl) phosphite, trilauryl phosphite, trioctadecyl phosphite, distearylpentaerythritol diphosphite, tris(2,4-di-tert-butylphenyl) phosphite, diisodecylpentaerythritol diphosphite, bis(2,4-di-tert-butylphenyl)pentaerythritol diphosphite, tristearylsorbitol triphosphite, tetrakis(2,4-d-tert-butylphenyl)-4,4'-biphenylene diphosphonite, bis(2,6-di-tert-butyl-4-methylphenyl)pentaerythritol diphosphite.
The individual additives are dissolved in the oil. To speed up the dissolution, the oil may be first heated or the additives may be first dissolved in a solvent.
The lubricant may also contain solid lubricant additives, for example graphite or molybdenum sulfide.





The examples below elucidate the invention in greater detail. The parts and percentages are parts and percentages by weight, unless stated otherwise.
EXAMPLE 1
The induction period of the oxidation of the oil samples by air containing 400 ppm of NO.sub.2 is determined under isothermal conditions using a differential scanning calorimeter (Du Pont Thermoanalysator 1090). The measurement is carried out at 170.degree. C. at a pressure of 8 bar. A reference mineral oil (Aral 136) containing 1% by volume of 1-decene added in order to boost its susceptibility to oxidation, is used as the base oil. The following amine stabilizers are added to the oil.
Aromatic Amines
A-1 An industrial mixture produced by reacting diphenylamine with diisobutylene, comprising
a) 3% of diphenylamine
b) 14% of 4-tert-butyldiphenylamine,
c) 30% of 4-tert-octyldiphenylamine, 4,4'-di-tert-butyldiphenylamine and 2,4,4'-tri-tert-butyldiphenylamine,
d) 29% of 4-tert-butyl-4'-tert-octyldiphenylamine, 2,2'- and 3,3'-di-tert-octyldiphenylamine and 2,4-di-tert-butyl-4'-tert-octyldiphenylamine,
e) 18% of 4,4'-di-tert-octyldiphenylamine,
f) 6% of 2,4-di-tert-octyl-4'-tert-butyldiphenylamine.
A-2 3,7-di-(tert-octyl)phenothiazine
Hindered Amines
H-1 di(2,2,6,6-tetramethylpiperidin-4-yl) sebacate
H-2 2,2,6,6-tetramethyl-4-piperidone
H-3 di(2,2,6,6-tetramethylpiperidin-4-yl) succinate
H-4 di(1,2,2,6,6-pentamethylpiperidin-4-yl) sebacate
H-5 2,3,6-trimethyl-2,6-diethyl--piperidone
H-6 2,2,6,6-tetramethyl-4-butylaminopiperidine
Table 1 lists the induction periods. The higher the induction period, the greater is the antioxidative effect of the stabilizer additives.
TABLE 1______________________________________Aromatic Hindered Induction periodamine amine (min)______________________________________-- -- 430.55% of A-1 -- 800.45% of A-1 0.10% of H-1 91.50.45% of A-1 0.10% of H-2 91.50.45% of A-1 0.10% of H-3 90.050.45% of A-1 0.10% of H-4 900.45% of A-1 0.10% of H-5 84.50.45% of A-1 0.10% of H-6 89______________________________________
EXAMPLE 2
Oxidation of hydrocarbons gives rise to oxygen-containing groups, for example hydroxyl, carboxyl or ester groups. Infra-red spectroscopy allows the amount of such groups to be measured and to determine therefrom the effect of the antioxidants. For this purpose samples of a reference mineral oil (Aral.RTM. 136) containing 1% by volume of 1-decene added in order to boost its susceptibility to oxidation, is heated under isothermal conditions in air containing 400 ppm of NO.sub.2, for 12 hours at a pressure of 8 bar. The IR absorption at 1730 cm.sup.-1 and 1630 cm.sup.-1 is then determined. The greater these values, the greater is the effect of the stabilizers. Tables 2a and 2b demonstrate the results at various temperatures.
TABLE 2a______________________________________Oxidation at 120.degree. C. IR AbsorptionStabilizer at 1730 cm.sup.-1 at 1630 cm.sup.-1______________________________________0.55% of A-1 0.471 1.0510.45% of A-1 + 0.10% of H-2 0.392 0.8390.45% of A-1 + 0.10% of H-3 0.424 0.8630.45% of A-1 + 0.10% of H-5 0.396 0.673______________________________________
TABLE 2b__________________________________________________________________________Oxidation at 150.degree. C. IR AbsorptionStabilizer at 1730 cm.sup.-1 at 1630 cm.sup.-1__________________________________________________________________________0.55% of A-1 0.557 1.8510.45% of A-1 + 0.10% of H-4 0.353 1.5000.65% of A-1 0.384 1.5990.45% of A-1 + 0.10% of H-4 + 0.10% of phenol B*) 0.330 1.2790.45% of A-1 + 0.10% of A-2 + 0.10% of H-4 0.340 1.443__________________________________________________________________________ *)phenol B = compound of the formula ##STR19##
EXAMPLE 3
The oxidation characteristics of the lubricating oils stabilized according to the invention were also tested by the TOST (turbine oxidation stability test) method according to ASTM D-943. For this purpose 60 ml of water are added to 300 ml of a mineral oil (Mobil STOC K 305) and the oil is heated in the presence of iron or copper wire at 95.degree. C. for 1000 hours, while oxygen is passed through. The measured parameters are formation of acids by determining the neutralization value TAN (mg of KOH/g of oil) and the amount of sludge formed.
For the stabilization either the amine A-1 is used on its own or in admixture with the hindered amine H-7 (2,2,6,6-tetramethyl-4-dodecyloxypiperidine), the total concentration of the stabilizers being always 0.25%, based on the oil.
______________________________________A-1 H-7 TAN (mg KOH/g of oil) Sludge (mg)______________________________________100% -- 0.46 3095% 5% 0.38 2790% 10% 0.30 2475% 25% 0.31 27______________________________________
EXAMPLE 4
By analogy with Example 1, the induction period of the oxidation is measured at 170.degree. C. For this purpose the following hindered amines are used:
H-8 N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)hexamethylenediamine
H-9 N,N'-bis(2,2,6,6-tetramethylpiperidin-4-yl)pentamethylenediamine
H-10 4-(methoxypropylamino)-2,2,6,6-tetramethylpiperidine
TABLE 4______________________________________Aromatic Hindered Induction periodamine amine (min)______________________________________-- -- 480.55% of A-1 -- 860.45% of A-1 0.10% of H-8 950.45% of A-1 0.10% of H-9 960.45% of A-1 0.10% of H-10 89______________________________________
EXAMPLE 5
The induction period of the oxidation is determined at 170.degree. C. as described in Example 1. The following aromatic amine is used for this purpose:
A-3 N-(p-octylphenyl)-1-naphthylamine
TABLE 5______________________________________Aromatic Hindered Induction periodamine amine (min)______________________________________0.55% of A-3 -- 52.80.45% of A-3 0.10% of H-7 66______________________________________
EXAMPLE 6
Oxidation resistance can be also determined by measuring the viscosity increase when the oil is treated with oxygen at elevated temperature.
For this purpose a stream of oxygen (1 liter/h) is passed through the oil at 150.degree. C. for 70 hours. The susceptibility of the oil to oxidation is first boosted by the addition of a catalytic amount of copper naphthenate. The viscosity of the oil is measured before and after the oxidation using an Ubbelode viscometer.
TABLE 6______________________________________ Percentage viscosityOil increase______________________________________base oil 168%base oil containing 3.4%0.6% of A-1 and0.15% of H-8______________________________________
Claims
  • 1. A lubricant composition which comprises
  • (A) a mineral or synthetic base oil or a mixture of such oils,
  • (B) at least one aromatic amine of the formula I ##STR20## in which R.sup.1 is C.sub.1 -C.sub.18 alkyl, C.sub.7 -C.sub.9 phenylalkyl, C.sub.5 -C.sub.12 cycloalkyl, phenyl, C.sub.7 -C.sub.18 alkylphenyl, C.sub.7 -C.sub.18 alkoxyphenyl or naphthyl, R.sup.2 is phenyl, C.sub.7 -C.sub.18 -alkylphenyl, C.sub.7 -C.sub.18 alkoxyphenyl or naphthyl, R.sup.3 is hydrogen, C.sub.1 -C.sub.12 alkyl, benzyl, allyl, methallyl, phenyl, or a group --CH.sub.2 SR.sup.4, R.sup.4 is C.sub.4 -C.sub.18 alkyl, --CH.sub.2 COO(C.sub.4 -C.sub.18 alkyl) or --CH.sub.2 CH.sub.2 COO(C.sub.4 -C.sub.18 alkyl), and
  • (C) at least one sterically hindered amine contain at least one trivalent group of the formula III ##STR21## in which R is hydrogen or methyl.
  • 2. The composition according to claim 1 which comprises as the component (B) at least one compound of the formula I, in which R.sup.1 is C.sub.1 -C.sub.4 alkyl, C.sub.7 -C.sub.9 phenylalkyl, cyclohexyl, phenyl, C.sub.10 -C.sub.18 alkylphenyl or naphthyl, R.sup.2 is C.sub.10 -C.sub.18 -alkylphenyl or phenyl, R.sup.3 is hydrogen, C.sub.1 -C.sub.8 alkyl, benzyl, allyl or a group --CH.sub.2 SR.sup.4, R.sup.4 is C.sub.8 -C.sub.18 alkyl or --CH.sub.2 COO(C.sub.8 -C.sub.18 alkyl).
  • 3. The composition according to claim 1 which comprises as the component (B) at least one compound of the formula I, wherein R.sup.1 and R.sup.2 independently of one another are phenyl or C.sub.10 -C.sub.18 alkylphenyl and R.sup.3 is hydrogen.
  • 4. The composition according to claim 1 which comprises as the component (B) 4,4'-di-tert-octyldiphenylamine, or a mixture of aromatic amines obtained by reacting diphenylamine with diisobutylene.
  • 5. The composition according to claim 1, in which R is hydrogen.
  • 6. The composition according to claim 1 which comprises as the component (C) a compound of the formula IV ##STR22## in which R is hydrogen, R.sup.11 is hydrogen or methyl, n is 2 and R.sup.12 is the diacyl radical of an aliphatic dicarboxylic acid having 4 to 12 carbon atoms.
  • 7. The composition according to claim 1 which comprises as the component (C) a compound of the formula V ##STR23## in which n is 1 or 2, R is hydrogen, R.sup.11 is hydrogen or methyl, R.sup.13 is hydrogen, C.sub.1 -C.sub.12 alkyl or a group of the formula ##STR24## and when n is 1, R.sup.14 is hydrogen or C.sub.1 -C.sub.12 alkyl, and when n is 2, R.sup.14 is C.sub.2 -C.sub.8 alkylene.
  • 8. The composition according to claim 1 which comprises as the component (C) a compound of the formula (IX) ##STR25## wherein R is hydrogen or methyl and R.sup.11 is hydrogen or methyl.
  • 9. The composition according to claim 1 which comprises 0.1 to 2% by weight of the total of (B) and (C), based on (A).
  • 10. The composition according to claim 1 wherein the ratio of (B) to (C) is 3-5 parts by weight of (B) per part by weight of (C).
  • 11. The composition according to claim 1 which additionally contains a phenolic antioxidant (D).
  • 12. The composition according to claim 1 which additionally contains an aliphatic or aromatic phosphite or phosphonite (E).
Priority Claims (1)
Number Date Country Kind
2737/88 Jul 1988 CHX
US Referenced Citations (18)
Number Name Date Kind
3218256 Edwards Nov 1965
3480635 Altwicker Nov 1969
3523910 Randell Aug 1970
3535243 Chao et al. Oct 1970
3539515 McCabe Nov 1970
3689484 Spilners Sep 1972
3773665 Braid Nov 1973
3822209 Knapp et al. Jul 1974
3844958 Anderson et al. Oct 1974
4370246 deVries et al. Jan 1983
4461898 Meier et al. Jul 1984
4525503 Cantatore Jun 1985
4540732 Spivack et al. Sep 1985
4601839 Lai Jul 1986
4691015 Behrens et al. Sep 1987
4692258 Rasberger et al. Sep 1987
4695599 Cantatore Sep 1987
4824601 Franklin Apr 1989
Foreign Referenced Citations (10)
Number Date Country
049133 Apr 1982 EPX
0059168 Sep 1982 EPX
0239536 Sep 1987 EPX
0286595 Oct 1988 EPX
WO8802007 Mar 1988 WOX
0933505 Aug 1963 GBX
1090688 Dec 1967 GBX
1140089 Jan 1969 GBX
1347141 Feb 1974 GBX
1438482 Jun 1976 GBX